The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Scientists from the Krembil Brain Institute and the University of Toronto have made an exciting discovery that could open new ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Increased exposure to air pollution in the form of particulate matter with a diameter of 2.5 µm or less (PM2.5) and nitrogen ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...